Multimodality Imaging in the Diagnosis, Risk Stratification and Management in the Patients with Dilated Cardiomyopathy. Practical recommendations

  • V. V. Lazoryshynets National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • S. V. Potashev National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • S. V. Fedkiv National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • A. V. Rudenko National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • R. M. Vitovskiy National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • K. V. Rudenko National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • S. A. Rudenko National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • L. M. Hrubyak National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • O. A. Mazur National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • O. O. Chizhevskaya National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.30702/ujcvs/20.3905/(guidelines)080-096
Keywords: dilated cardiomyopathy, prognosis, treatment, echocardiography, cardiac magnetic resonance imaging, nuclear imaging

Abstract

Dilated cardiomyopathy (DCM) is defined by left ventricular (LV) or biventricular dilation with systolic dysfunction in the absence of abnormal loading conditions or coronary heart disease significant enough to explain these alterations. This is a heterogeneous entity, often with a genetic background. Cardiovascular imaging is extremely important for diagnosis, prognosis and risk stratification, as well as further treatment and management guidance. Multimodality imaging approach assures the most comprehensive evaluation of all the issues related to DCM. The present paper aims to provide detailed recommendations for the use of multimodality imaging according to clinical requirements from the standpoint of modern evidence-based data and adopted to existing practice in Ukraine. Choice for one or the other imaging method should be based on the very clinical condition and individual context. “Clinically relevant” imaging techniques as well as “applicable” tools are distinguished. There are still certain gaps in the evidence base on the influence of multimodality imaging upon the management and treatment of the patients with DCM. Therefore, ongoing research is of big importance.

References

  1. Donal E, Delgado V, Bucciarelli-Ducci C, Galli E, Haugaa KH, Charron P, et al. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2019 Oct 1;20(10):1075–93. https://doi.org/10.1093/ehjci/jez178
  2. Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, et al. Proposal for a revised definition of dilated cardiomyopathy,hypokineticnon-dilatedcardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37:1850–8. https://doi.org/10.1093/eurheartj/ehv727
  3. Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017;390:400–14. https://doi.org/10.1016/S0140-6736(16)31713-5
  4. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–6. https://doi.org/10.1093/eurheartj/ehm342
  5. Donal E, Lip GY, Galderisi M, Goette A, Shah D, Marwan M, et al. EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2016;17:355–83. https://doi.org/10.1093/ehjci/jev354
  6. Bouabdallaoui N, Mouquet F, Lebreton G, Demondion P, Le Jemtel TH, Ennezat PV. Current knowledge and recent development on management of peripartum cardiomyopathy. Eur Heart J Acute Cardiovasc Care 2017;6:359–66. https://doi.org/10.1177/2048872615612465
  7. Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2017;38:2649–62. https://doi.org/10.1093/eurheartj/ehx321
  8. Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67:2996–3010. https://doi.org/10.1016/j.jacc.2016.03.590
  9. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–70. https://doi.org/10.1093/ehjci/jev014
  10. Galderisi M, Cosyns B, Edvardsen T, Cardim N, Delgado V, Di Salvo G, et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017;18:1301–10. https://doi.org/10.1093/ehjci/jex244
  11. Celeng C, Leiner T, Maurovich-Horvat P, Merkely B, de Jong P, Dankbaar JW, et al. Anatomical and functional computed tomography for diagnosing hemodynamically significant coronary artery disease: a meta-analysis. JACC Cardiovasc Imaging. 2019;12:1316–25. https://doi.org/10.1016/j.jcmg.2018.07.022
  12. Soriano CJ, Ridocci F, Estornell J, Jimenez J, Martinez V, De Velasco JA. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium… enhanced cardiovascular magnetic resonance. J Am Coll Cardiol. 2005;45:743–8. https://doi.org/10.1016/j.jacc.2004.11.037
  13. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200. https://doi.org/10.1093/eurheartj/ehw128
  14. Fatkin D, Yeoh T, Hayward CS, Benson V, Sheu A, Richmond Z, et al. Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy. Circ Cardiovasc Genet. 2011;4:342–8. https://doi.org/10.1161/CIRCGENETICS.110.958918
  15. George A, Figueredo VM. Alcoholic cardiomyopathy: a review. J Card Fail. 2011;17:844–9. https://doi.org/10.1016/j.cardfail.2011.05.008
  16. Caballero L, Kou S, Dulgheru R, Gonjilashvili N, Athanassopoulos GD, Barone D, et al. Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study. Eur Heart J Cardiovasc Imaging 2015;16: 1031–41. https://doi.org/10.1093/ehjci/jev083
  17. Sugimoto T, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, et al. Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging. 2017;18:833–40. https://doi.org/10.1093/ehjci/jex140
  18. Farsalinos KE, Daraban AM, Unlu S, Thomas JD, Badano LP, Voigt JU. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE Inter-Vendor Comparison Study. J Am Soc Echocardiogr. 2015;28:1171–81,e2. https://doi.org/10.1016/j.echo.2015.06.011
  19. Boyd A, Stoodley P, Richards D, Hui R, Harnett P, Vo K, et al. Anthracyclines induce early changes in left ventricular systolic and diastolic function: a single centre study. PLoS One. 2017;12:e0175544. https://doi.org/10.1371/journal.pone.0175544
  20. Holland DJ, Marwick TH, Haluska BA, Leano R, Hordern MD, Hare JL, et al. Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus. Heart. 2015;101:1061–6. https://doi.org/10.1136/heartjnl-2014-307391
Published
2020-05-26
How to Cite
1.
Lazoryshynets VV, Potashev SV, Fedkiv SV, Rudenko AV, Vitovskiy RM, Rudenko KV, Rudenko SA, Hrubyak LM, Mazur OA, Chizhevskaya OO. Multimodality Imaging in the Diagnosis, Risk Stratification and Management in the Patients with Dilated Cardiomyopathy. Practical recommendations. ujcvs [Internet]. 2020Apr.27 [cited 2024Dec.26];(2 (39):80-6. Available from: http://cvs.org.ua/index.php/ujcvs/article/view/358
Issue
Ukrainian Journal of Cardiovascular Surgery No 2 (39) 2020
Section
RECOMMENDATIONS

Most read articles by the same author(s)